{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:39:59Z","timestamp":1787625599209,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Michael Smith Foundation","award":["#16835"],"award-info":[{"award-number":["#16835"]}]},{"name":"Canadian Institutes of Health Research New Investigator award","award":["MSH147810"],"award-info":[{"award-number":["MSH147810"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.05.040","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:45:46Z","timestamp":1538127946000},"page":"419-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-3807","authenticated-orcid":false,"given":"Liam R.","family":"Brunham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-8028","authenticated-orcid":false,"given":"Isabelle","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Cermakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B. John","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2248-9663","authenticated-orcid":false,"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib3","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","article-title":"Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?","volume":"38","author":"Nordestgaard","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.001","article-title":"Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration","volume":"22","author":"EAS Familial Hypercholesterolemia Studies Collaboration","year":"2016","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib6","doi-asserted-by":"crossref","first-page":"6D","DOI":"10.1016\/0002-9149(93)90003-U","article-title":"Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a \"founder effect\"","volume":"72","author":"Davignon","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOL.0000000000000487","article-title":"Familial hypercholesterolemia: experience from the French-Canadian population","volume":"29","author":"Paquette","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.9.2.211","article-title":"Homozygous familial hypercholesterolemia among French Canadians in Quebec province","volume":"9","author":"Moorjani","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib9","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib10","first-page":"326","article-title":"The british Columbia familial hypercholesterolemia registry","volume":"55","author":"Wong","year":"2013","journal-title":"BC Medical Journal"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cjca.2016.08.016","article-title":"Contemporary trends in the management and outcomes of patients with familial hypercholesterolemia in Canada: a prospective observational study","volume":"33","author":"Brunham","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib14","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib15","article-title":"Attainment of recommended lipid targets in patients with familial hypercholesterolemia: real-world experience with PCSK9 inhibitors","author":"Razek","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib16","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib17","first-page":"354","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ open"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib19","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Scientific steering committee on behalf of the Simon broome register group","volume":"303","author":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjca.2014.09.028","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"Genest","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1373\/clinchem.2017.279422","article-title":"Imputation of baseline LDL cholesterol concentration in patients with familial hypercholesterolemia on statins or ezetimibe","volume":"64","author":"Ruel","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ecl.2008.11.007","article-title":"Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety","volume":"38","author":"Hou","year":"2009","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/2047487314533218","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"22","author":"Watts","year":"2015","journal-title":"European journal of preventive cardiology"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","article-title":"The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"Journal of clinical lipidology"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacl.2017.07.008","article-title":"Cardiovascular disease in familial hypercholesterolemia: validation and refinement of the Montreal-FH-SCORE","volume":"11","author":"Paquette","year":"2017","journal-title":"Journal of clinical lipidology"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib30","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib31","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the american heart association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib32","series-title":"Familial Hypercholesterolaemia: Identification and Management","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib34","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOL.0000000000000163","article-title":"Targeted next-generation sequencing in monogenic dyslipidemias","volume":"26","author":"Hegele","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib37","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1194\/jlr.P058891","article-title":"Targeted next-generation sequencing to diagnose disorders of HDL cholesterol","volume":"56","author":"Sadananda","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib38","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","article-title":"The human gene mutation database: 2008 update","volume":"1","author":"Stenson","year":"2009","journal-title":"Genome Med."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cjca.2013.01.008","article-title":"Western Database of Lipid Variants (WDLV): a catalogue of genetic variants in monogenic dyslipidemias","volume":"29","author":"Fu","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cjca.2017.01.008","article-title":"Barriers to the implementation of lipoprotein apheresis in Canada","volume":"33","author":"Filler","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.05.040_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2018.05.015","article-title":"Simplified Canadian definition for familial hypercholesterolemia","author":"Ruel","year":"2018","journal-title":"Can. J. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018302831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018302831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:48:54Z","timestamp":1558630134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018302831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":42,"alternative-id":["S0021915018302831"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.040","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}